Two Sigma Advisers’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20,940
| Closed | -$118K | – | 2736 |
|
|
2022
Q2 | $118K | Sell |
20,940
-12,650
| -38% | -$71.3K | ﹤0.01% | 2371 |
|
|
2022
Q1 | $376K | Sell |
33,590
-18,680
| -36% | -$209K | ﹤0.01% | 2123 |
|
|
2021
Q4 | $763K | Buy |
52,270
+36,750
| +237% | +$536K | ﹤0.01% | 1707 |
|
|
2021
Q3 | $466K | Buy |
15,520
+9,950
| +179% | +$299K | ﹤0.01% | 1953 |
|
|
2021
Q2 | $258K | Sell |
5,570
-1,070
| -16% | -$49.6K | ﹤0.01% | 2187 |
|
|
2021
Q1 | $398K | Buy |
+6,640
| New | +$398K | ﹤0.01% | 2105 |
|